Bartlett & Co. Wealth Management LLC Ice Cure Medical Ltd. Transaction History
Bartlett & Co. Wealth Management LLC
- $6.97 Trillion
- Q3 2024
A detailed history of Bartlett & Co. Wealth Management LLC transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 250 shares of ICCM stock, worth $272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$272
Previous $185,000
17.3%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ICCM
# of Institutions
16Shares Held
195KCall Options Held
0Put Options Held
0-
Ubs Group Ag59.9KShares$65,2840.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$28,6780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$27,8600.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$20,1920.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$15,8880.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $40.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.